Fifty Shades: Controversies and Updates in Head and Neck Melanoma

Monday, September 30, 2024

1:00 PM – 2:00 PM EDT

Location: MBCC, 207

CME/MOC Credit: 1

Disclosure(s):

Tiffany A. Glazer, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Brittny N. Tillman, MD, FACS:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Mirabelle B. Sajisevi, MD:

faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

PROGRAM DESCRIPTION: Management of cutaneous melanoma of the head and neck is undergoing a transformation. Changes in AJCC staging, controversies relating to threshold for sentinel lymph node biopsy and neck dissection, and increasing role of immunotherapy in management of melanoma are all important areas that are dramatically altering diagnostic and therapeutic practice patterns. Otorhinolaryngologists play an important role in management of patients with head and neck cutaneous melanoma, and need to stay up to date on surgical controversies, emerging therapeutics, and combinatorial therapies.

This panel discussion will focus on informing otorhinolaryngologists about key updates relating to sentinel lymph node biopsy, approaches to management of cN0 nodal basins upon discovery of positive sentinel nodes for patients with head and neck cutaneous melanoma, the integration of systemic therapy in management of advanced head and neck melanoma, and the nuances of utilizing injectable immunotherapy agents in clinical practice. Additionally, practice pearls and pitfalls relating to setting up a program focused on injectable immunotherapy for otorhinolaryngologists will be described utilizing a case based approach.

Audience members will have the opportunity to engage in focused discussion in the areas of panelists' presentations.

Learning Objectives:

Describe the technique, pearls & pitfalls in sentinel lymph node biopsy for cutaneous melanoma; examine controversies in management of cN0 nodal basin upon discovery of positive sentinel lymph nodes.
Identify role of systemic therapy and its interactions with surgical therapy for head and neck cutaneous melanoma.
Define role of the head and neck surgeon in intra-lesion injectable therapies in managing advanced head and neck cutaneous melanoma.

Moderator(s)

Aru Panwar, MD

Associate Professor, Head & Neck Surgical Oncology
Methodist Estabrook Cancer Center & Creighton University School of Medicine
Omaha, Nebraska, United States

Disclosure information not submitted.

Resources

Panelist(s)

Aru Panwar, MD

Associate Professor, Head & Neck Surgical Oncology
Methodist Estabrook Cancer Center & Creighton University School of Medicine
Omaha, Nebraska, United States

Disclosure information not submitted.

Resources
Tiffany A. Glazer, MD

Program Director
University of Wisconsin
Madison, WI, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.

Resources
Brittny N. Tillman, MD, FACS

Associate Professor, Otolaryngology-Head & Neck Surgery
UT Southwestern Medical Center
Dallas, TX, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Mirabelle B. Sajisevi, MD

Associate Professor, Residency Program Director
University of Vermont Medical Center
Burlington, VT, United States

Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.